Itemoids

You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.

2026April › 10

Wegovy

3 months ago

Researchers analysed more than 400,000 social media posts in a bid to identify lesser-known issues linked to widely used GLP-1 medications semaglutide and tirzepatide.
Eli Lilly loses share in India’s GLP‑1 market as cheap semaglutide generics surge, while Novo holds steady after deep price cuts to defend Ozempic, Wegovy.

page 1 of 1